4.7 Review

Paracrine signaling in islet function and survival

Journal

JOURNAL OF MOLECULAR MEDICINE-JMM
Volume -, Issue -, Pages -

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00109-020-01887-x

Keywords

Paracrine signaling; Islet function; Survival; Islet biology; Diabetes

Funding

  1. American Diabetes Association [1-18-IBS-105]
  2. NIH [R01DK114356]
  3. Baylor College of Medicine Nutrition and Obesity Pilot and Feasibility Fund

Ask authors/readers for more resources

The pancreatic islet is a dense cellular network comprised of several cell types with endocrine function vital in the control of glucose homeostasis, metabolism, and feeding behavior. Within the islet, endocrine hormones also form an intricate paracrine network with supportive cells (endothelial, neuronal, immune) and secondary signaling molecules regulating cellular function and survival. Modulation of these signals has potential consequences for diabetes development, progression, and therapeutic intervention. Beta cell loss, reduced endogenous insulin secretion, and dysregulated glucagon secretion are hallmark features of both type 1 and 2 diabetes that not only impact systemic regulation of glucose, but also contribute to the function and survival of cells within the islet. Advancing research and technology have revealed new islet biology (cellular identity and transcriptomes) and identified previously unrecognized paracrine signals and mechanisms (somatostatin and ghrelin paracrine actions), while shifting prior views of intraislet communication. This review will summarize the paracrine signals regulating islet endocrine function and survival, the disruption and dysfunction that occur in diabetes, and potential therapeutic targets to preserve beta cell mass and function.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Deficiency of Stat1 in CD11c+ Cells Alters Adipose Tissue Inflammation and Improves Metabolic Dysfunctions in Mice Fed a High-Fat Diet

Antu Antony, Zeqin Lian, Xiaoyuan Dai Perrard, Jerry Perrard, Hua Liu, Aaron R. Cox, Pradip Saha, Lothar Hennighausen, Sean M. Hartig, Christie M. Ballantyne, Huaizhu Wu

Summary: This study investigated the role of Stat1 in obesity-induced MDC polarization and inflammation, using mice with specific knockout of Stat1 in MDCs. The results showed that Stat1 in MDCs plays a crucial role in promoting M1-like polarization, contributing to AT inflammation, insulin resistance, and metabolic dysfunctions in obese mice.

DIABETES (2021)

Article Multidisciplinary Sciences

Loss of bone morphogenetic protein-binding endothelial regulator causes insulin resistance

Hua Mao, Luge Li, Qiying Fan, Aude Angelini, Pradip K. Saha, Huaizhu Wu, Christie M. Ballantyne, Sean M. Hartig, Liang Xie, Xinchun Pi

Summary: The role of endothelial BMPER function in glucose homeostasis is crucial, and overexpression of BMPER has been shown to alleviate insulin resistance and hyperglycemia in diabetic mice.

NATURE COMMUNICATIONS (2021)

Review Endocrinology & Metabolism

Contributions of microRNAs to Peripheral Insulin Sensitivity

Kang Ho Kim, Sean M. Hartig

Summary: MicroRNA levels are correlated with metabolic diseases and regulate central metabolic pathways to maintain organismal energy balance and metabolic homeostasis. Research on the roles and regulation of microRNAs in conferring insulin sensitivity in peripheral tissues is progressing, with sequencing technologies being used to define the target spectrum of microRNAs in metabolic diseases. The emerging roles of exosomal microRNAs as endocrine signals in regulating lipid and carbohydrate metabolism are also discussed.

ENDOCRINOLOGY (2022)

Article Physiology

Heightened levels of plasma growth differentiation factor 15 in men living with HIV

Neeti Agarwal, Claudia E. Ramirez Bustamante, Huaizhu Wu, Reina Armamento-Villareal, Jordan E. Lake, Ashok Balasubramanyam, Sean M. Hartig

Summary: Plasma biomarkers reflecting energy balance disorders in people living with HIV (PLWH) are limited. Growth differentiation factor 15 (GDF15) abundance in plasma has been associated with negative energy balance, obesity, and metabolic diseases. This study compared plasma GDF15 levels in PLWH, HIV-negative individuals, and mouse models expressing the HIV accessory protein Vpr. Elevated plasma GDF15 levels were found in PLWH and Vpr mouse models, and correlated with certain metabolic parameters.

PHYSIOLOGICAL REPORTS (2022)

Review Endocrinology & Metabolism

Adipose Tissue Dysfunction and Energy Balance Paradigms in People Living With HIV

Claudia E. Ramirez Bustamante, Neeti Agarwal, Aaron R. Cox, Sean M. Hartig, Jordan E. Lake, Ashok Balasubramanyam

Summary: Over the past 4 decades, the clinical care of people living with HIV has shifted from treatment of infections to the management of chronic comorbidities. Adipose tissue dysfunction plays a role in the changes in body composition and adiposity that occur in PLWH, increasing their risk for cardiovascular disease. Conventional therapies are ineffective for managing cardiometabolic risk in this patient population, highlighting the need for further research and understanding.

ENDOCRINE REVIEWS (2023)

Review Endocrinology & Metabolism

Immune Cells Gate White Adipose Tissue Expansion

Aaron R. Cox, Natasha Chernis, Peter M. Masschelin, Sean M. Hartig

ENDOCRINOLOGY (2019)

Article Gastroenterology & Hepatology

Constitutive Androstane Receptor Differentially Regulates Bile Acid Homeostasis in Mouse Models of Intrahepatic Cholestasis

Kang Ho Kim, Jong Min Choi, Feng Li, Bingning Dong, Clavia Ruth Wooton-Kee, Armando Arizpe, Sayeepriyadarshini Anakk, Sung Yun Jung, Sean M. Hartig, David D. Moore

HEPATOLOGY COMMUNICATIONS (2019)

No Data Available